WaferGen Biosystems, Inc.
(OTC:WGBS) (BULLETIN BOARD: WGBS) , a leading developer of state-of-the-art
genetic analysis systems, today announced a new, innovative service for gene-expression
profiling of thousands of genes using the SmartChip(TM) Real-Time PCR System.
By taking advantage of the SmartChip Real-Time PCR system, WaferGen will offer
universities, pharmaceutical and diagnostic companies a service that utilizes
pathway-specific gene panels to discover and validate new biomarkers.
The company also announced today that it is moving to a new facility to support
the SmartChip services and the expansion of manufacturing and R&D functions.
The new WaferGen SmartChip Service will be made available to a few select customers
in December and made more broadly available in the first quarter of 2010. The
SmartChip Service offerings will be expanded early next year to include a miRNA
expression panel. Researchers will get early access to the technology and the
benefit of new and upcoming gene panels. In addition, academic researchers can
get preliminary data at a reasonable cost to submit for grants to complete more
advanced studies.
"Our new service, run by our experienced scientists, will introduce users
to the throughput benefits of SmartChip to maximize the discovery of new biomarkers,"
said Alnoor Shivji, Chairman and CEO, WaferGen. "For the first time, researchers
can interrogate thousands of genes in a single run using Real-Time PCR and detect
gene expression differences that could be missed using microarray technology."
The WaferGen SmartChip Service is targeted at scientists involved in the discovery
and validation of molecular biomarkers. The initial product to be run on the
SmartChip platform is the SmartChip Human Oncology Gene Panel that provides
pathway based gene expression profiling for Oncology. It may also be used for
Immunology, Metabolic and Stem Cell research. The 5,184 nano-well SmartChip
uses a small amount of biological material to query a thousand genes in a single
sample, enabling discovery of biomarkers while saving researchers time and money.
By applying Quantitative Real-Time PCR Expression Profiling, the SmartChip system
combines the gene expression profiling of microarrays with the sensitivity and
dynamic range of Real-Time PCR, the gold standard of gene expression studies.
The 27 built-in controls offer added quality assurance to the results.